The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer
Open accessAbstract
Radiation resistance in breast cancer resulting in residual lesions or recurrence is a significant cause to radiotherapy failure. Cancer‐associated fibroblasts (CAFs) and radiotherapy‐induced senescent CAFs can further lead to radiation resistance and tumor immunosuppressive microenvironment. Here, an engineering cancer‐cell‐biomimetic nanoplatform is constructed for dual‐targeted clearance of CAFs as well as senescent CAFs. The nanoplatform is prepared by 4T1 cell membrane vesicles chimerized with FAP single‐chain fragment variable as the biomimetic shell for targeting of CAFs and senescent CAFs, and PLGA nanoparticles (NPs) co‐encapsulated with nintedanib and ABT‐263 as the core for clearance of CAFs and senescent CAFs, which are noted as FAP‐CAR‐CM@PLGA‐AB NPs. It is evidenced that FAP‐CAR‐CM@PLGA‐AB NPs directly suppressed the tumor‐promoting effect of senescent CAFs. It also exhibits prolonged blood circulation and enhanced tumor accumulation, dual‐cleared CAFs and senescent CAFs, improved radiation resistance in both acquired and patient‐derived radioresistant tumor cells, and effective antitumor effect with the tumor suppression rate of 86.7%. In addition, FAP‐CAR‐CM@PLGA‐AB NPs reverse the tumor immunosuppressive microenvironment and enhance systemic antitumor immunity. The biomimetic system for dual‐targeted clearance of CAFs and senescent CAFs provides a potential strategy for enhancing the radio‐sensitization of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Immune-related effects, including cGAS–STING activation and increased immune cell infiltration, have also been described following nanoparticle-assisted irradiation [18,23,26,91].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Cancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 5,689
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
In vivo near-infrared fluorescence imaging
Frangioni, J. V. (2003) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2003.08.007 · Cited by 2,653
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
Deng, L., Liang, H., Burnette, B., Beckett, M., Darga, T., Weichselbaum, R. R., & Fu, Y.-X. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67313 · Cited by 2,105
Turning foes to friends: targeting cancer-associated fibroblasts
Chen, X., & Song, E. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0004-1 · Cited by 1,879
The Mechanisms of Vesicle Budding and Fusion
Bonifacino, J. S., & Glick, B. S. (2004) · Cell · doi:10.1016/s0092-8674(03)01079-1 · Cited by 1,856
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Research works printed but not linked: 3
- Loganadane G., 2017, Clin. Transl. Radiat. Oncol., 4, 46
- Liu A., 2013, Chin. J. Cancer., 32, 483
- Pagar R. R., 2022, ACS Appl. Bio Mater., 8, 2161
Cited by
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
“Nanostructures can trigger clearance of activated and senescent CAFs [96], and regulation of CAFs by nanoparticles can disrupt cancer metastasis and invasion [97].”
BackgroundSelf-citationAdvances in nanoparticle-based radiotherapy for cancer treatment
He, M., Chen, S., Yu, H., Fan, X., Wu, H., Wang, Y., Wang, H., & Yin, X. (2024) · iScience · doi:10.1016/j.isci.2024.111602 · Cited by 68
“Metal and metal oxide NPs are widely used in RT, such as AuNPs, silver NPs (AgNPs), zinc oxide NPs (ZnO NPs), cerium oxide NPs (CeO 2 NPs) and so on, mainly to improve the damage efficiency of tumor cells through enhancing the absorption of radiation while reducing the damage to normal tissues.”
InfluentialLiao, T., Chen, X., Qiu, F., Zhang, X., Wu, F., Zhao, Z., Xu, M., Chen, M., Shen, J., Shen, Q., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03217-0 · Cited by 47
Selenium‐Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization
Qiao, R., Yuan, Z., Yang, M., Tang, Z., He, L., & Chen, T. (2024) · Advanced Science · doi:10.1002/advs.202402039 · Cited by 39
The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways
Li, D., Shao, F., Yu, Q., Wu, R., Tuo, Z., Wang, J., Ye, L., Guo, Y., Yoo, K. H., Ke, M., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01776-7 · Cited by 35
“To solve TAF-induced RT resistance, Jian et al. [158]. created a nanoplatform to clear TAFs and senescent TAFs (which also could induce RT resistance), obviously improving RT resistance.”
Background
Metadata
- Authors
- Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C.
- Affiliations
- Wuhan Union Hospital (CN)
- Shanghai Jiao Tong University (CN)
- Department of Pharmacy Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China
- Venue
- Small
- Publisher
- Wiley
- Published
- 2024-01-12
- Volume
- 20
- Issue
- 25
- Pages
- e2309279-e2309279
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W4390795819
- Cited by
- 33
- References
- 63
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 8
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Small (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (82073402, 81901884, 82272821)
- Natural Science Foundation of Shanghai Municipality (22ZR1467600)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cancer-associated fibroblasts, radioresistance (biology), breast cancer, biomimetic nanoplatform, cell membrane vesicles, PLGA nanoparticles, nintedanib, navitoclax, radiosensitization, immunosuppressive tumor microenvironment, tumor microenvironment
- MeSH terms
- Cancer-Associated Fibroblasts, Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Breast Neoplasms, Female, Humans, Radiation Tolerance, Cellular Senescence, Biomimetics, Biomimetic Materials, Cell Line, Tumor, Mice, Nanoparticles, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer. https://app.cochat.ai/papers/10.1002/smll.202309279
- The paper
- Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C. (2024). Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer. Small. https://doi.org/10.1002/smll.202309279
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.